Zhongxing BioTech(SZ:002772) Zhong Guo Zheng Quan Bao - Zhong Zheng Wang·2025-11-26 04:20Summary of Key Points Core Viewpoint - The company has approved a guarantee limit for its subsidiaries for the year 2025, aiming to enhance financing efficiency and support operational needs [2][3]. Group 1: Guarantee Overview - The company plans to provide a total guarantee limit of up to 1.97 billion yuan for certain wholly-owned subsidiaries and some wholly-owned sub-subsidiaries in 2025 [2]. - The guarantee limit is divided into two categories: up to 680 million yuan for subsidiaries with an asset-liability ratio above 70%, and up to 1.29 billion yuan for those below 70% [2]. Group 2: Adjustment of Guarantee Limits - The company has adjusted the guarantee limit for its wholly-owned subsidiary, transferring 10 million yuan from Xinxiang Xinghe Biotechnology Co., Ltd. to Anyang Zhongxing Mushroom Industry Technology Co., Ltd. [4]. - After the adjustment, the guarantee limit for both subsidiaries is set at 60 million yuan each [4]. Group 3: Progress of Guarantees - On November 19, 2025, the company signed a guarantee contract with a bank for a maximum guarantee of 40 million yuan for Anyang Zhongxing [5]. - Additionally, a loan of 120 million yuan was secured for Xinxiang Zhongxing, with a guarantee contract signed on November 20, 2025, for the same amount [6]. - A further guarantee of 50 million yuan was established for Wuhou Zhongxing on November 24, 2025 [6]. Group 4: Total External Guarantees - As of the announcement date, the total external guarantees provided by the company amount to approximately 1.14 billion yuan, representing 34.40% of the company's latest audited net assets attributable to shareholders [8]. - There are no overdue guarantees or guarantees involved in litigation [8].